Spectral AI, Inc. (MDAIW) company profile
Close on Oct 30, 2026Market cap $49.24MP/E –Yield –
About Spectral AI
Surgical & Medical Instruments & Apparatus, SIC 3841
Spectral AI, Inc. develops predictive medical diagnostic solutions driven by artificial intelligence. Its primary offering is the DeepView System, which integrates multispectral imaging optics and sensors with proprietary algorithms to evaluate wound healing potential. The platform delivers immediate, binary assessments that differentiate between non-healing and healing tissue, particularly for burn indications. Its operational framework incorporates two commercial models: a software licensing structure featuring maintenance, data hosting, and algorithmic updates, alongside a proprietary imaging hardware component. These clinical tools are designed to assist healthcare professionals in making timely treatment and triage decisions across emergency rooms, trauma centers, and burn units.
The company maintains its principal executive offices in Dallas, Texas. Outside the United States, Spectral AI has obtained regulatory authorization to market its burn assessment technology in the United Kingdom, where commercial distribution is scheduled to commence. Additionally, through the Australian Special Access Scheme, the company has delivered diagnostic devices to three hospitals situated in Melbourne, Perth, and Sydney.
Summary of the business section of Spectral AI's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Spectral AI, Inc.
- Headquarters
- Dallas, TX
- Address
- 2515 Mckinney Ave #1000 75201
- Phone
- (212) 492-3000
- Website
- spectral-ai.com
- Employees
- 65, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Forvis Mazars, LLP, Dallas, Texas
Stock & identifiers
- Ticker
- MDAIW
- Other tickers
- MDAI
- Exchange
- Nasdaq
- IPO date
- Feb 16, 2021
- Shares outstanding
- 32M, Aug 11, 2026
- Public float
- $72.00M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1833498
- CUSIP
- 84757T113
- ISIN
- US84757T1135
- FIGI
- BBG00Z32ZBL8
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Vincent S. Capone | Chief Executive Officer | 286,450 |
| John Michael DiMaio | Director | 5,404,755 |
| Deepak Sadagopan | Director | 25,000 |
| Richard John Cotton | Director | 111,477 |
| Marion Ann Snyder | Director | 25,000 |
| Martin C.B. Mellish | Director | 24,398 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| John Michael DiMaio Former Principal Executive Officer | $200.00K | – | – | $207.50K | – | $407.50K | +325% |
| Vincent Capone Chief Executive Officer and Former Chief Financial Officer and General Counsel | $440.00K | $250.00K | $225.00K | $59.75K | $43.52K | $1.02M | +3% |
| Stan Micek Chief Operating Officer | $360.00K | $108.00K | – | – | – | $468.00K | +73% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Feb 16, 2021
- Offer price
- $10.00
- First trading day
- Mar 26, 2021
- First-day close
- $9.65-3.5%
- Lock-up ends (est.)
- Sep 22, 2021
“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one -third of one redeemable warrant.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“At December 31, 2025 had 65 full-time employees in the United States”
Corporate history
Events identified from SEC filings